clinic
present
respiratori
infect
caus
differ
viral
pathogen
similar
make
etiolog
diagnosi
difficult
rapid
virolog
method
permit
specif
sensit
diagnosi
earli
stage
ill
assist
clinician
make
therapeut
decis
also
prevent
nosocomi
infect
alert
onset
epidem
use
standard
diagnost
method
viral
isol
cell
cultur
antigen
detect
assay
result
long
delay
final
result
avail
molecular
techniqu
enabl
major
advanc
speed
sensit
laboratori
diagnosi
viral
respiratori
infect
within
group
assay
polymeras
chain
reaction
pcr
use
commonli
although
sever
method
must
explor
order
improv
applic
across
rang
viral
pathogen
myint
mani
rna
virus
includ
respiratori
virus
multiplex
revers
transcript
rt
pcr
assaybas
diagnosi
shown
rapid
sensit
specif
gilbert
et
al
coira
et
al
moreov
assay
allow
coamplif
one
target
rna
sequenc
small
quantiti
specimen
thu
provid
use
inform
signific
mix
infect
prognost
recrudesc
respiratori
diseas
multiplex
rtpcr
system
incorpor
diagnosi
routin
increas
throughput
specimen
reduc
analyt
cost
associ
screen
multipl
organ
gilbert
et
al
previou
studi
coira
et
al
multiplex
rtnest
pcr
assay
describ
detect
simultan
identifi
influenza
b
c
virus
respiratori
syncyti
virus
rsv
type
b
gener
detect
adenoviru
serotyp
virus
primari
import
sinc
infect
produc
rang
mild
respiratori
ill
fatal
pneumonia
caus
consider
morbid
excess
death
children
elderli
peopl
immunocompromis
individu
throughout
world
fleme
cross
arola
et
al
dowel
et
al
assay
integr
clinic
virolog
surveil
prove
use
rapid
sensit
diagnost
method
nevertheless
mani
viral
respiratori
pathogen
human
parainfluenza
virus
type
rhinovirus
among
caus
agent
common
infecti
diseas
worldwid
especi
children
year
age
virus
happen
rsv
influenza
b
virus
caus
rang
respiratori
ill
mild
upper
respiratori
tract
symptom
bronchiol
exacerb
asthma
primari
pneumonia
associ
death
mcmillan
et
al
nicholson
et
al
apalsch
et
al
arruda
et
al
hand
human
coronavirus
also
worldwid
distribut
infect
age
group
gwaltney
hruskova
et
al
inde
coronavirus
thought
respons
approxim
common
cold
well
lower
respiratori
tract
infect
infant
exacerb
asthma
mcintosh
et
al
johnston
et
al
addit
import
defin
role
enterovirus
etiolog
agent
childhood
obstruct
bronchiol
et
al
usual
relat
enter
diseas
casa
et
al
trallero
et
al
consequ
second
multiplex
rtnest
pcr
assay
develop
standardis
simultan
detect
identifi
follow
virus
human
parainfluenza
virus
type
coronavirus
involv
respiratori
infect
human
type
gener
detect
human
enterovirus
rhinovirus
applic
multiplex
assay
analysi
nucleic
acid
extract
clinic
specimen
therefor
use
simultan
detect
common
viral
respiratori
pathogen
simultan
use
diagnost
tool
facilit
undertak
prophylact
measur
also
provid
earli
inform
circul
epidem
respiratori
virus
use
check
efficaci
futur
vaccin
total
clinic
specimen
use
valid
multiplex
rtnest
pcr
assay
specimen
receiv
virolog
studi
respiratori
viru
laboratori
nation
centr
microbiolog
cnm
instituto
de
salud
carlo
iii
majadahonda
madrid
spain
follow
nasopharyng
aspir
children
present
acut
respiratori
syndrom
bronchiol
bronchial
asthma
pneumonia
influenzalik
ill
submit
severo
ochoa
hospit
madrid
spain
nasal
wash
immunosupress
patient
hiv
cancer
organ
transplant
receiv
respiratori
infect
diagnosi
purpos
nose
throat
swab
individu
present
influenzalik
ill
taken
physician
comunidad
de
madrid
spain
one
hundr
eightyf
specimen
total
describ
select
neg
influenza
rsv
adenoviru
detect
use
multiplex
rtnest
pcr
assay
previous
describ
coira
et
al
sixteen
specimen
posit
former
multiplex
assay
use
check
specif
assay
describ
prototyp
strain
human
parainfluenza
virus
type
coronavirus
enterovirus
rhinovirus
indic
tabl
use
posit
control
refer
strain
enterovirus
rhinovirus
obtain
american
type
cultur
collect
atcc
manassa
va
assess
sensit
pcr
run
addit
control
prepar
two
dilut
contain
molecul
clone
amplifi
product
type
human
parainfluenza
virus
coronaviru
echoviru
rhinoviru
serotyp
pgemt
vector
system
promega
coira
et
al
use
check
extract
process
amplif
effici
presenc
inhibitor
clinic
specimen
control
retrotranscript
reaction
limit
dilut
rna
human
parainfluenza
virus
type
human
echoviru
human
rhinoviru
human
coronaviru
includ
batch
test
sampl
detect
failur
transcript
reaction
primer
human
parainfluenza
virus
design
conserv
region
haemagglutinin
gene
primer
coronavirus
design
also
conserv
region
spike
protein
gene
primer
rhinovirus
enterovirus
design
polyprotein
gene
noncod
region
ncr
region
case
computerassist
analysi
sequenc
avail
public
databas
macaw
program
multipl
align
construct
analysi
workbench
ncbi
bethesda
use
genbank
access
number
viral
sequenc
use
primer
design
shown
tabl
ii
total
primer
use
first
amplif
individu
virus
human
parainfluenza
virus
coronavirus
picornaviru
group
well
intern
control
identifi
subsequ
nest
pcr
use
primer
criteria
use
design
oligonucleotid
rang
size
amplicon
produc
similar
reaction
kinet
sequenc
properti
primer
shown
tabl
iii
primer
use
amplifi
intern
control
describ
coira
et
al
nucleic
acid
either
viru
present
clinic
specimen
infect
cell
cultur
extract
ml
sampl
use
guanidinium
thiocyan
extract
method
previous
describ
casa
et
al
neg
control
treat
follow
procedur
lysi
buffer
includ
molecul
clone
amplifi
product
intern
control
process
dri
pellet
resuspend
ml
rnasefre
steril
water
sigma
singl
step
combin
rtpcr
amplif
reaction
henceforth
call
multiplex
assay
perform
use
promega
access
rtpcr
system
kit
promega
consist
pcr
mixtur
contain
mm
mgso
mm
datp
dgtp
dctp
dttp
pmol
specif
primer
human
parainfluenza
virus
coronavirus
pmol
specif
primer
enterovirus
rhinovirus
ml
reaction
buffer
u
amv
revers
transcriptas
rt
u
tfl
dna
polymeras
ml
aliquot
rnadna
extract
ad
final
volum
ml
amplif
carri
thinwal
reaction
tube
sorenson
bioscienc
ut
peltier
thermal
cycler
mj
research
watertown
sampl
subject
initi
cycl
min
min
cycl
condit
pcr
cycl
sec
min
min
final
incub
min
follow
nest
pcr
mixtur
multiplex
assay
contain
mm
mgcl
perkin
elmer
branchburg
nj
mm
datp
dgtp
dctp
dttp
amersham
pharmacia
biotech
piscataway
nj
pmol
specif
primer
human
parainfluenza
virus
coronavirus
pmol
specif
primer
enterovirus
rhinovirus
mm
trishcl
ph
mm
nh
u
amplitaq
dna
polymeras
perkin
elmer
ml
aliquot
first
reaction
ad
final
volum
ml
pcr
sampl
heat
min
cycl
condit
cycl
sec
min
sec
final
incub
min
ml
aliquot
nucleic
acid
extract
also
ad
final
volum
ml
rtpcr
reaction
mixtur
perform
multiplex
rtnest
pcr
assay
describ
previous
coira
et
al
henceforth
call
multiplex
assay
thermal
cycl
condit
perform
multiplex
assay
adapt
use
time
multiplex
assay
ml
aliquot
first
reaction
multiplex
assay
ad
final
volum
ml
nest
pcr
cycl
condit
ident
multiplex
assay
describ
perform
analysi
time
one
thermalcycl
nest
pcr
product
analys
electrophoresi
seakem
agaros
fmc
rockland
gel
contain
mgml
ethidium
bromid
trisbor
buffer
size
pcr
product
bp
intern
control
bp
coronaviru
bp
coronaviru
bp
parainfluenza
viru
type
bp
parainfluenza
viru
type
bp
parainfluenza
viru
type
bp
enterovirus
averag
bp
parainfluenza
viru
type
bp
rhinovirus
averag
tabl
iii
fig
due
high
variabl
gene
region
amplifi
nest
primer
enteroviru
rhinoviru
genom
fragment
obtain
length
regard
group
virus
nest
fragment
length
could
bp
enterovirus
bp
rhinovirus
size
pcr
product
obtain
multiplex
assay
describ
previous
coira
et
al
sampl
aliquot
recept
use
assay
store
later
confirm
pcr
result
posit
result
consid
valid
pcr
result
match
two
differ
aliquot
analys
consecut
day
addit
posit
result
parainfluenza
virus
confirm
multiplex
rtpcr
assay
describ
previous
aguilar
et
al
cell
cultur
human
lung
mucoepidermoid
carcinoma
cell
line
indirect
immunofluoresc
assay
ifa
posit
result
enterovirus
confirm
isol
human
embryon
fibroblast
hef
cell
line
ifa
posit
result
coronavirus
rhinovirus
confirm
dna
sequenc
discord
result
assay
obtain
aliquot
respiratori
sampl
analys
high
sensit
nest
pcr
precaut
must
taken
prevent
contamin
reaction
tube
product
amplifi
previous
target
dna
specimen
control
prepar
reagent
process
sampl
aliquot
respiratori
specimen
nest
pcr
assay
carri
safeti
cabinet
locat
separ
laboratori
away
area
amplifi
product
analys
cabinet
equip
independ
batch
reagent
micropipett
set
steril
reagent
tube
filter
pipett
tip
specimen
collect
ml
viru
transport
medium
mem
gibco
brl
life
technolog
paisley
scotland
penicillin
uml
streptomycin
mgml
biowhittak
walkersvil
mycostatin
uml
sigma
st
loui
mi
bovin
serum
albumin
merck
darmstadt
germani
semiconflu
monolay
cell
madindarbi
canin
kidney
mdck
cell
human
laryng
epidermoid
carcinoma
hef
cell
line
use
primari
viral
isol
human
parainfluenza
virus
influenza
virus
rsv
enterovirus
rhinovirus
coronavirus
monolay
inocul
ml
homogenis
sampl
adsorpt
enhanc
centrifug
rpm
hr
hef
cell
line
maintain
eagl
minim
essenti
medium
supplement
fetal
calf
fig
serial
tenfold
dilut
copi
clone
amplifi
product
viru
intern
control
follow
human
parainfluenza
type
lane
type
lane
type
lane
type
lane
greer
respect
coronavirus
strain
lane
lane
human
echoviru
lane
rhinoviru
serotyp
lane
intern
control
lane
serum
uiml
penicillin
mgml
streptomycin
mdck
cell
also
maintain
eagl
minim
essenti
medium
penicillinstreptomycin
supplement
mgml
trypsin
cell
maintain
eagl
minim
essenti
medium
supplement
mgml
trypsin
cell
collect
stain
standard
method
kendal
et
al
monoclon
antibodi
use
detect
fusion
protein
strain
parainfluenza
viru
type
haemagglutinin
strain
parainfluenza
virus
type
obtain
chemicon
intern
inc
temecula
ca
monoclon
antibodi
use
detect
enterovirus
also
obtain
chemicon
ifa
carri
fluorescein
isothiocyan
fitc
conjug
goat
antimous
igg
sigma
comparison
result
obtain
propos
multiplex
rtnest
pcr
assay
isol
cell
cultur
ifa
altern
multiplex
rtpcr
assay
human
parainfluenza
virus
perform
comput
percentag
sensit
specif
griner
et
al
comparison
diagnost
assay
evalu
mcnemar
test
primer
design
multiplex
rtnest
pcr
assay
amplifi
haemagglutinin
gene
human
parainfluenza
virus
type
coronaviru
spike
protein
gene
partial
end
ncr
gene
partial
end
gene
enterovirus
rhinovirus
primer
examin
ensur
met
essenti
criteria
optim
pcr
primer
dieffenbach
et
al
edward
gibb
henegariu
et
al
check
could
use
togeth
multiplex
reaction
similar
condit
amplif
primer
anneal
temperatur
concentr
calcul
empir
standardis
experiment
g
c
content
melt
temperatur
length
primer
chosen
analys
use
primerselect
dnastar
inc
madin
wi
primer
also
test
possibl
primer
interact
hairpin
signific
theoret
misprim
identifi
templat
test
possibl
palindrom
sequenc
primer
use
align
sequenc
databas
nation
centr
biotechnolog
inform
ncbi
use
basic
local
align
search
tool
blast
primer
design
ensur
final
reaction
product
could
easili
differenti
basi
size
shown
tabl
iii
primer
select
bp
g
c
content
less
equal
thu
anneal
temperatur
thermocycl
paramet
denatur
anneal
extens
time
systemat
optimis
anneal
temperatur
first
second
round
amplif
respect
select
give
maximum
product
yield
specif
data
shown
locat
oligonucleotid
primer
design
amplifi
virus
allow
type
parainfluenza
virus
type
coronavirus
serogroup
gener
detect
human
enterovirus
rhinovirus
describ
specif
primer
simultan
detect
enterovirus
rhinovirus
design
ncr
region
polyprotein
gene
descript
sens
primer
rtpcr
nest
pcr
assay
specif
amplif
fragment
enterovirus
ncr
found
arola
et
al
huttunen
et
al
howev
improv
differenti
electrophoresi
assay
also
includ
correspond
antisens
degener
primer
see
tabl
iii
thu
take
advantag
differ
rel
size
likewis
primer
amplifi
coronaviru
spike
protein
design
produc
fragment
bp
differ
serogroup
order
permit
identif
electrophoresi
multiplex
rtnest
pcr
assay
test
specif
viral
target
tabl
fig
misprim
observ
primer
set
mix
either
human
parainfluenza
virus
type
coronavirus
type
enterovirus
rhinovirus
templat
product
expect
size
obtain
viral
templat
presenc
primer
specif
product
clearli
separ
identifi
seakem
agaros
gel
viru
control
materi
cell
culturegrown
parainfluenza
virus
coronaviru
enterovirus
rhinovirus
tissu
cultur
grown
coronaviru
clinic
specimen
contain
wild
type
strain
fig
product
specif
amplicon
obtain
also
confirm
sequenc
analysisespeci
rhinovirus
coronavirusesdu
lack
easi
reliabl
method
detect
expect
analysi
specimen
contain
respiratori
virus
influenza
rsv
adenoviru
citomegaloviru
multiplex
assay
show
amplifi
product
case
data
shown
sensit
detect
human
parainfluenza
virus
coronavirus
enterovirus
rhinovirus
nest
primer
set
use
individu
similar
multiplex
reaction
sensit
evalu
use
serial
tenfold
dilut
seri
clone
pcr
product
obtain
viru
first
reaction
detect
level
molecul
clone
amplifi
product
achiev
parainfluenza
viru
type
fig
lane
parainfluenza
viru
type
lane
echoviru
lane
rhinoviru
serotyp
lane
parainfluenza
virus
type
fig
lane
respect
human
coronaviru
strain
lane
limit
detect
molecul
clone
amplifi
product
addit
comparison
result
obtain
multiplex
assay
obtain
viru
isol
cell
cultur
use
tenfold
dilut
refer
strain
made
evalu
sensit
assay
sensit
obtain
follow
tissu
cultur
infect
dose
tcid
parainfluenza
virus
type
echoviru
tcid
parainfluenza
virus
type
rhinoviru
serotyp
data
shown
multiplex
rtnest
pcr
assay
evalu
use
panel
combin
nose
throat
swab
nasopharyng
aspir
obtain
season
major
specimen
obtain
infant
two
year
age
although
age
repres
studi
tabl
iv
result
show
specimen
infect
parainfluenza
viru
type
andor
rhinoviru
type
sampl
came
children
month
nucleic
acid
extract
cdna
synthesi
independ
aliquot
taken
ifa
isol
cell
cultur
set
day
synthesi
amplif
cdna
perform
multiplex
assay
detect
influenza
b
c
virus
rsv
type
b
gener
detect
adenovirus
also
multiplex
assay
describ
work
specimen
select
neg
multiplex
assay
rest
posit
influenza
b
viru
rsv
type
b
adenoviru
last
sampl
use
confirm
specif
multiplex
assay
also
detect
possibl
coinfect
respiratori
syndrom
laboratori
result
obtain
differ
techniqu
use
studi
shown
tabl
iv
detect
infect
virus
cell
cultur
andor
detect
antigen
ifa
provid
posit
result
distribut
follow
posit
parainfluenza
virus
one
posit
coronavirus
detect
cell
cultur
two
posit
enterovirus
two
posit
rhinovirus
detect
cell
cultur
identifi
convent
method
ten
specimen
posit
respiratori
virus
influenza
b
viru
rsv
type
b
adenoviru
one
specimen
coinfect
parainfluenza
viru
rsv
detect
viru
detect
specimen
specimen
posit
ifa
isol
cell
cultur
also
confirm
multiplex
assay
addit
new
approach
abl
detect
posit
specimen
parainfluenza
viru
type
addit
specimen
parainfluenza
viru
type
parainfluenza
viru
type
addit
specimen
addit
rhinovirus
enterovirus
also
detect
multiplex
assay
confirm
sequenc
nest
pcr
fragment
four
specimen
presenc
viru
detect
grow
cell
cultur
ifa
multiplex
assay
confirm
one
specimen
infect
enteroviru
three
rhinovirus
posit
result
parainfluenza
virus
confirm
altern
multiplex
rtnest
pcr
develop
detect
parainfluenza
virus
type
aguilar
et
al
addit
one
specimen
infect
viru
grew
cell
cultur
could
identifi
also
detect
multiplex
assay
fig
analysi
panel
clinic
specimen
multiplex
rtnest
pcr
assay
lane
combin
nose
throat
swab
nasopharyng
aspir
lane
neg
sampl
lane
parainfluenza
type
lane
parainfluenza
type
lane
parainfluenza
type
coinfect
rhinoviru
lane
lane
rhinoviru
lane
enterovirus
lane
parainfluenza
type
simultan
coinfect
rhinoviru
lane
identifi
coronaviru
sequenc
fragment
obtain
nest
pcr
confirm
similar
strain
specimen
coinfect
two
differ
virus
determin
addit
viru
detect
total
specimen
specimen
assay
multiplex
assay
posit
rsv
type
see
tabl
iv
rsv
type
b
adenoviru
influenza
b
viru
detect
specimen
total
specimen
panel
posit
viru
combin
method
specimen
neg
sampl
detect
pcr
product
seen
although
interestingli
citomegaloviru
one
specimen
grown
cell
cultur
percentag
sensit
specif
develop
multiplex
rtpcr
comput
previous
describ
griner
et
al
comparison
multiplex
assay
result
detect
ifa
cell
cultur
show
new
multiplex
rtnest
pcr
assay
far
sensit
convent
method
p
mcnemar
test
absolut
agre
altern
multiplex
rtpcr
method
assay
abil
multiplex
reaction
mixtur
detect
presenc
one
viru
templat
start
materi
assess
prepar
variou
combin
viral
templat
data
shown
detect
capabl
improv
combin
multiplex
assay
multiplex
reaction
abl
detect
eight
differ
virus
well
intern
control
fig
lane
c
multipl
respiratori
virus
observ
specimen
see
tabl
v
rsv
enteroviru
one
specimen
rsv
parainfluenza
viru
type
one
specimen
rsv
parainfluenza
viru
type
two
specimen
parainfluenza
virus
detect
multiplex
rtpcr
assay
rsv
could
isol
cell
cultur
detect
ifa
adenoviru
parainfluenza
viru
type
detect
two
specimen
one
could
adenoviru
isol
parainfluenza
viru
howev
could
detect
cell
cultur
ifa
rhinovirus
detect
parainfluenza
viru
type
two
specimen
parainfluenza
virus
confirm
viral
cultur
parainfluenza
viru
type
four
specimen
two
specimen
parainfluenza
virus
detect
viral
cultur
parainfluenza
viru
type
five
specimen
three
specimen
parainfluenza
virus
confirm
viral
cultur
parainfluenza
viru
type
one
specimen
parainfluenza
viru
could
confirm
cell
cultur
ifa
parainfluenza
virus
confirm
multiplex
assay
human
parainfluenza
virus
aguilar
et
al
interestingli
coinfect
two
differ
multiplex
rtnest
pcr
assay
previous
describ
coira
et
al
simultan
detect
influenza
b
c
virus
rsv
type
b
gener
detect
adenoviru
specimen
infect
one
viru
parainfluenza
coronaviru
rhinoviru
enteroviru
respiratori
viru
group
accord
type
assay
use
analys
month
year
ifacc
immunofluoresc
assaycel
cultur
rtpcr
revers
transcriptionpolymeras
chain
reaction
rhinovirus
found
one
specimen
coinfect
detect
rhinovirus
show
differ
pcr
product
size
electrophoresi
agaros
gel
see
materi
method
confirm
sequenc
fragment
obtain
nest
pcr
type
possibl
due
nonavail
public
sequenc
rhinovirus
circul
differ
respiratori
virus
period
year
make
complex
elucid
individu
contribut
global
respiratori
diseas
moreov
pattern
respiratori
viru
activ
seem
chang
within
differ
age
group
among
patient
enclos
highrisk
group
therefor
rapid
accur
etiolog
diagnosi
viral
infect
essenti
choos
adequ
antivir
therapi
prevent
nosocomi
spread
opportunist
secondari
infect
control
measur
would
undoubtedli
reduc
hospit
stay
treatment
cost
unnecessari
use
antibiot
woo
et
al
furthermor
addit
assay
routin
diagnosi
would
help
defin
role
everi
respiratori
viru
relat
differ
popul
group
therefor
perform
epidemiolog
studi
varieti
diagnost
test
avail
current
detect
one
import
viral
respiratori
pathogen
gilbert
et
al
freymuth
et
al
valassina
et
al
eugeneruellan
et
al
osiowi
et
al
aguilar
et
al
etc
commerci
avail
multiplex
rtpcr
assay
detect
respiratori
virus
describ
fan
et
al
prodess
hexaplex
assay
detect
simultan
rsv
type
b
influenza
b
virus
parainfluenza
virus
type
howev
detect
adenoviru
import
respiratori
tract
pathogen
kehl
et
al
rhinovirus
coronavirus
constitut
common
upper
respiratori
tract
pathogen
could
caus
seriou
complic
et
al
arbour
et
al
parainfluenza
viru
type
appar
frequent
virul
describ
et
al
besid
hexaplex
assay
rel
rapid
sensit
current
avail
direct
techniqu
labori
costli
moreov
virus
enterovirus
rhinovirus
coronavirus
repeatedli
found
clinic
specimen
patient
respiratori
infect
role
well
defin
difficult
detect
current
method
paper
new
multiplex
rtnest
pcr
assay
abl
identifi
simultan
eight
differ
virus
respiratori
tract
describ
evalu
primer
design
conserv
region
haemagglutinin
gene
parainfluenza
virus
type
spike
protein
gene
coronavirus
genom
partial
ncr
gene
rhinovirus
enterovirus
genom
sensit
detect
parainfluenza
virus
coronavirus
rhinovirus
enterovirus
nest
primer
set
use
multiplex
reaction
test
detect
level
molecul
cloneddna
parainfluenza
virus
type
rhinoviru
serotyp
echoviru
molecul
cloneddna
parainfluenza
virus
coronaviru
achiev
fig
addit
tcid
parainfluenza
virus
type
echoviru
tcid
parainfluenza
virus
type
rhinoviru
serotyp
detect
data
shown
crossreact
respiratori
virus
influenza
rsv
adenoviru
citomegaloviru
found
demonstr
specif
assay
detect
much
respiratori
virus
possibl
propos
analys
clinic
specimen
use
multiplex
assay
describ
multiplex
assay
one
describ
coira
et
al
multiplex
assay
use
multiplex
rtnest
pcr
assay
possibl
detect
simultan
identifi
fourteen
respiratori
virus
test
requir
approxim
hr
process
time
capabl
screen
simultan
high
quantiti
clinic
specimen
instead
perform
differ
assay
detect
type
separ
therefor
decreas
cost
increas
throughput
specimen
simultan
use
multiplex
assay
first
step
perform
epidemiolog
studi
determin
frequent
everi
pathogen
could
caus
seriou
complic
children
year
old
elderli
peopl
immunocompromis
patient
furthermor
accur
diagnosi
would
effect
prevent
unnecessari
antibiot
treatment
two
hundr
one
specimen
season
use
valid
new
multiplex
assay
see
fig
frozen
sever
year
major
obtain
children
year
age
see
tabl
iv
specimen
initi
test
parallel
multiplex
assay
ifa
andor
isol
cell
cultur
fiftysix
specimen
posit
one
method
sixteen
posit
multiplex
assay
ifa
isol
cell
cultur
specimen
posit
ifa
isol
cell
cultur
present
differ
viru
detect
multiplex
assay
among
one
coinfect
parainfluenza
virus
rsv
therefor
specimen
neg
method
multiplex
assay
detect
presenc
respiratori
virus
addit
specimen
neg
could
evalu
ifa
viral
isol
see
tabl
iv
differ
could
due
limit
sensit
convent
method
also
nose
throat
swab
optim
clinic
sampl
detect
virus
ifa
compar
nasopharyng
aspir
elli
et
al
case
isol
cell
cultur
loss
infect
could
relat
differ
factor
defici
transport
andor
conserv
sampl
concomit
microbi
contamin
clinic
specimen
total
specimen
posit
method
use
among
coinfect
two
differ
virus
see
tabl
iv
v
therefor
although
ifa
use
mostli
diagnosi
respiratori
infect
caus
parainfluenza
virus
type
viru
isol
consid
gold
standard
parainfluenza
virus
detect
sometim
unabl
confirm
posit
specimen
parainfluenza
virus
obtain
use
multiplex
assay
attempt
determin
viral
cultureand
ifaneg
multiplex
assayposit
specimen
parainfluenza
virus
proper
posit
multiplex
assay
describ
aguilar
et
al
use
confirm
posit
result
case
enterovirus
gold
standard
detect
viral
cultur
follow
ifa
identif
confirm
cytopat
effect
obtain
howev
diagnosi
rhinovirus
respiratori
tract
infect
limit
poor
sensit
cell
cultur
necess
confirm
use
acid
sensit
assay
serolog
diagnosi
virtual
imposs
well
due
abund
rhinovirus
serotyp
hyypia
et
al
infect
caus
rhinovirus
among
common
infecti
diseas
worldwid
import
reliabl
diagnost
tool
capabl
detect
presenc
clinic
specimen
relev
molecular
assayssuch
rtpcr
use
detect
rhinovirus
enterovirus
nasopharyng
aspir
infant
respiratori
tract
infectionha
alreadi
demonstr
atmar
georghiou
johnson
et
al
halonen
et
al
present
studi
incorpor
detect
rhinovirus
enterovirus
rtpcr
assay
also
allow
identif
parainfluenza
virus
coronavirus
fact
found
respiratori
infect
within
specimen
use
valid
multiplex
assay
caus
rhinovirus
hand
describ
coronavirus
antibodi
rose
coronavirus
strain
serogroup
could
protect
coronavirus
strain
serogroup
vice
versa
macnaughton
reason
perform
epidemiolog
studi
import
distinguish
serogroup
therefor
primer
detect
presenc
coronavirus
respiratori
specimen
also
includ
mixtur
reaction
nevertheless
although
describ
coronavirus
produc
upper
respiratori
tract
infect
one
specimen
test
infect
coronaviru
underdiagnosi
respiratori
infect
caus
coronavirus
studi
could
due
fact
specimen
analys
belong
children
two
year
old
sever
lower
respiratori
tract
infecti
diseas
number
dual
infect
found
valid
new
multiplex
assay
high
definit
could
detect
assay
like
dual
infect
play
greater
role
diseas
describ
previous
kehl
et
al
respiratori
infect
observ
multiplex
assay
confirm
method
rsv
found
one
specimen
enteroviru
three
specimen
parainfluenza
virus
type
adenovirus
found
two
specimen
parainfluenza
viru
type
coinfect
rhinovirus
type
parainfluenza
virus
even
type
rhinovirus
also
detect
see
tabl
v
clinic
aspect
distinct
viral
respiratori
infect
indistinguish
yun
et
al
garcia
garcia
et
al
diagnost
tool
abl
detect
dual
infect
small
quantiti
clinic
specimen
extrem
use
evalu
clinic
consequ
simultan
presenc
sever
pathogen
respiratori
tract
sens
analysi
simul
clinic
sampl
origin
specimen
reveal
multiplex
rtnest
pcr
assay
clearli
capabl
simultan
detect
presenc
fourteen
virus
high
low
copi
number
detect
method
ifa
viral
isol
less
adequ
although
ifa
reveal
presenc
influenza
b
virus
rsv
parainfluenza
virus
antigen
epitheli
cell
clinic
specimen
wide
use
diagnosi
adenoviru
coronavirus
enterovirus
rhinovirus
neither
isol
cell
cultur
appropri
detect
coinfect
virul
viru
destroy
cell
monolay
slower
growth
viru
could
evid
would
make
difficult
identifi
coinfect
cell
cultur
respiratori
virus
comparison
new
multiplex
rtnest
pcr
assay
convent
method
viral
isol
cell
cultur
viral
antigen
detect
ifa
individu
rtpcr
assay
parainfluenza
virus
detect
perform
statist
analysi
result
prove
new
multiplex
assay
sensit
convent
method
p
present
sensit
rtpcr
assay
parainfluenza
virus
detect
accordingli
detect
respiratori
pathogen
molecular
method
prove
sensit
convent
viral
cultur
ifa
method
advantag
virus
test
time
singl
techniqu
find
consist
studi
report
previous
tantivanich
et
al
atmar
et
al
gilbert
et
al
freymuth
et
al
liolio
et
al
addit
combin
rtpcr
assay
nest
pcr
potenti
increas
sensit
whole
approach
reason
multiplex
assay
detect
viral
cultureand
ifaposit
clinic
specimen
addit
posit
sampl
would
otherwis
miss
convent
method
nevertheless
necessari
consid
potenti
problem
inher
pcr
fals
neg
due
reaction
failur
fals
posit
caus
contamin
appear
unexpect
band
neg
control
complet
pcr
failur
presum
fals
neg
distinguish
nonamplif
result
ad
control
templat
nonrel
target
sequenc
ballabio
et
al
edward
gibb
thu
addit
copi
intern
control
everi
reaction
tube
ensur
multiplex
assay
accur
work
conclus
test
respiratori
specimen
use
multiplex
rtnest
pcr
assay
describ
previous
coira
et
al
describ
permit
simultan
detect
identif
fourteen
respiratori
viral
pathogen
clinic
specimen
multiplex
assay
constitut
rapid
sensit
specif
less
expens
altern
convent
method
avoid
applic
mani
differ
assay
analys
one
specimen
fourteen
differ
respiratori
virus
improv
rapid
diagnosi
respiratori
diseas
accordingli
reduc
nosocomi
transmiss
limit
unnecessari
antibiot
use
improv
clinic
assist
result
appropri
therapi
follow
accur
diagnosi
viral
infect
produc
similar
clinic
symptom
also
could
appli
epidemiolog
studi
surveil
respiratori
virus
involv
abil
detect
dual
infect
identifi
pathogen
impli
assay
use
determin
import
produc
seriou
complic
group
patient
result
present
also
indic
multiplex
approach
great
potenti
detect
group
pathogen
caus
cluster
diseas
similar
sign
symptom
